Research output per year
Research output per year
Personal profile
Expertises
Molecular Pathology with focus on mutational analysis in cancers and Human papillomavirus derived cancers; Expertise on clinical diagnostic technologies for cervical screening purposes; Clinical technologies for detection of HPV in non-gynaecology cancers; Detection and characterization of treatment defining mutations in tumors; Biobanks; Guidelines; Private-public collaborations
Main research areas
Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers
Current research
Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers
Potential conflicts of interest
Jesper Bonde has within the last five years served as a paid advisor to Roche Molecular Systems, and Genomica SAU, and has received honoraria or travel costs compensation from Hologic, Roche, QIAGEN, Genomica, and BD Diagnostics, European Cytology Association, International Cytology Association, International Papillomavirus Society, and American Society of Clinical Virology for lectures. He is principal investigator on studies funded by BD Diagnostics.
Fingerprint
Dive into the research topics where Jesper Hansen Bonde is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
Dhillon, S. K., Simoens, C., Cuypers, L., Bode, J., Bonde, J., Corbisier, P., Cocuzza, C. E., Van Ranst, M. & Arbyn, M., 24 Feb 2023, In: Virology journal. 20, 1, p. 35 35.Research output: Contribution to journal › Journal article › Research › peer-review
-
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Arbyn, M., Cuschieri, K., Poljak, M. & Bonde, J., 25 Aug 2023, (E-pub ahead of print) In: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.Research output: Contribution to journal › Journal article › Research › peer-review
-
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
Vink, F. J., Meijer, C. J. L. M., Hesselink, A. T., Floore, A. N., Lissenberg-Witte, B. I., Bonde, J. H., Pedersen, H., Cuschieri, K., Bhatia, R., Poljak, M., Oštrbenk Valenčak, A., Hillemanns, P., Quint, W. G. V., Del Pino, M., Kenter, G. G., Steenbergen, R. D. M., Heideman, D. A. M. & Bleeker, M. C. G., 8 Feb 2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e827-e834 21 p., ciac433.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
Bhatia, R., Alcaniz Boada, E., Bonde, J. H., Quint, W. G. V., Xu, L., Ejegod, D. M., Cuschieri, K. & Arbyn, M., Mar 2023, In: Journal of Clinical Pathology. 76, 3, p. 172-176 5 p., jclinpath-2021-207864.Research output: Contribution to journal › Journal article › Research › peer-review
-
Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study
Ring, L. L., Thomsen, L. T., Haedersdal, M., Sørensen, S. S., Bonde, J. H., Lok, T. T., Larsen, H. K. & Kjaer, S. K., Apr 2023, In: Transplant Infectious Disease. 25, 2, e14019.Research output: Contribution to journal › Journal article › Research › peer-review